<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 73 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page72.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=73">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 73 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 73</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=73"><img src="../thumb/73.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>42 / 2020-04                                                   Central Nervous System - 1.6 / 1.7 / 1.7.1
   argy somet. lead.to trans.coma, hear.loss, vasculit., GI disturbs. incl.   lirium, sev.depress. with/without suicid.behav., unmask.of dement.,   Side effects: Hypersens.reacts., abnorm. involunt. movem., dys-
   gastralg., trans.alopec., skin reacts.incl.tox. epiderm.necrolys./Stev.  sev.gener.choreoathetoid & dyston.movem.aft. prolong.admin., exag-  kines., hyperkines., invol.jerks, paranoid ideat., psychot.episod., de-
   Johns.syndr./erythema multiforme, revers.Fanconi syndr., amenor-  gerat.resp.movem.& exacerbat.oculogyric.crises with postencephalit.   press.with/-out suicid. tendenc., mania, hallucinat., cardio-arrhythm.,
   rh., irreg. periods, weight incr., non-sev.periph.oed., fibrinog. reduct.,   parkinsonism, trans.leucopen., may inhib.lactat.  ang.pect., orthostat.hypotens., fluctuat. in therapeut.respons., GI
   bleed.time incr., bld.dyscras.incl.anaem./ leucopen./pancytopen.,   Special precautions: Discont.levodopa 8 hrs. bef. start.Carbilev,   disturbs., weight gain, oed., lassit., hiccups, insomn., depress., noc-
   hyperammonaem.without liv.funct.test chang., hyperammonaem.  excret.in breast milk., bronch. asthma, emphys., sev.pulm./CV dis.,   turn. excitat., diurnal excitat., somnol., sudd.sleep onset episod.,
   assoc.with neurolog.sympts., convuls.incr., revers.dement./ cerebr.  MI hist., pept. ulc., psychot.states, open-angle glauc., ren.funct. im-  dizzin., palpitat., musc.cramps, hypoton., leg pain, torsion dyston.,
   atrophy/ Parkinsonism/postur.trem./somnol.  pairm., urin.retent., diab.mellit., concurr. anaesthet., anticonvuls.,   dyspn., libido changes, prurit., skin rash, taste changes, bld.dys-
   Warnings and special precautions: Cross. placenta, excret.in   haloperidol, phenothiazin. & antihypertens.  cras., urine discolourat.
   breast milk, excl.pregn.prior to start., liv.funct.tests incl.prothromb.rate   Drug interactions: Cocaine incr.risk of card. arrhythm.  Special precautions: Abrupt.withdr.may result in neurolept.
   bef. admin.& monit.period.dur.first 6 mnths. esp. pts.at risk, confirm.  LECARDOP, (Ranbaxy) Sun Pharma [P/S]  malign.-like syndr., observ.for depress./ suicid. tendenc/ser.behav.
   abnorm.low prothromb.rate, partic.in associat.with other biolog.ab-  changes, psychot. disord. hist/psychotherapeut agents admin., MI
   normalit.req. discontin., hepat.fail with pancreatit.incr.fatal outcome   Carbidopa 25(25) mg, levodopa 100(250) mg.  hist., atrial/nodal or ventric.arrhythm., reg.CV/ hepat/ haematopoi-
                                Indications: Parkinson.dis.& syndr.
   risk, monit.weight gain as risk fact.for polycyst.ovary syndr., ren.insuff.,   et.& ren.funct.assessm.dur. extend. ther., poss.dos.reduct.of concom.
   sev.seiz./ neurolog. impairm./anticonvuls.ther.poss.risk fact., monit.  (S4) TABS. 45/5.4.1/0764, 0765.  sympathomimet., abrupt.withdr.of other anti-Parkinson. meds.not
                                3000000-001: 25/100 mg, 100, R327,76
   with concom.neurolept./MAOI/ antidepress./ benzodiazepin./primi-  recomm., monit.IOP, glauc., monit. diab.& med.dos., coron.insuffic.,
   done/ phenobarb./phenytoin, zidovudine/carbamazep. toxic., INR   3000001-001: 25/250 mg, 100, R448,16  convuls. disord./pept.ulc.hist., subclinic.osteoporos./ osteomalacia,
                                Dosage: Admin.on empty stomach. Titrate dos. Other agents with
   monit.with coumar.-type anticoags., elderly, hyperammonem.assoc.  monit BP of hypertens.pts., incr. injur. risk with rapid mobilisat., con-
   with neurolog. sympt., bld.tests recomm.bef.init.ther./surg./ spont.   except.of levodopa alone may be cont.with poss.dos.adjustm.neces-  com.psychoact. meds., avoid halothane in anaesthes., alert pt.to
                                sitat. When tfd. pts.from levodopa monother.monit.caref. specif. for
   bleed./bruis., consid.benef.vs.risk in pts. with SLE, ac.abdom.pain,   invol.movements which may req.dos. reduct.  poss. sudd.sleep onset/somnol., poss.compuls. behav. (eg. gambling/
   discont.ther.with pancreatit./ metab.investig.advis.in case of susp.  hypersexual.), prot.rich meals imp. levodopa absorpt.from GIT, drug
   urea cycle enzymat.defic., false posit.in urin. test.of poss.diabet., sev.  Init.dos: Init 1 tab of Lecardop 25/100 tab 3x/day. Incr.dos.by 1   depend./ abuse potent.where cognit./behaviour.disturbs attribut.to
                                tab.dly/on alt.days as necess until 8 25/100 tabs/day reach. Lecar-
   liv.damage and pancreatit. risk decr. with age, discont.ther.in case of   incr.med quantit.against med.advice & motor disabilit.
   liv. damage detect., discont.concom.salicylat.as precaut.  dop 25/250: Init dos: ½ tab.1-2xdly.incr.by ½ tab.dly./on alt. days   Drug interactions: Fe sulph.decr.max.plasma conc & AUC, meto-
                                as necess.
   Drug interactions: Effs.of other psychotrop. potent., rais.phenobarb.  clopramide incr.absorpt.rate, neurolept.& opioids inhibit.act., sym-
   plasma conc., primidone plasma lev.incr., decr.phenytoin tot.plasma   Maint: Indiv.& adjust accord.to respons. Where more levodopa   pathomimet. eff. potent., other anti-parkinson.agents are permiss.
                                reqd.substit.with Lecardop 25/250 tab. Incr.by ½-1 tab.every day/
   lev. conc.& free form incr.with poss.overdos.sympt., metabol.of lamo-  but effs.may be intensif.
   trig.reduc.& mean half-life incr., zidovud.plasma conc.incr., tox.eff.of   other day to max.8 tabs.dly.
                                Exper.with carbidopa tot.dly.dos.exceed 200 mg limit.
   carbamazep. potent., anti-epilept.eff.antagon.by antidepress.& neuro-  Contraindications: narr.angle glauc., hist. of melanoma/undiag.  OXPOLA, (Sanofi) Gulf [P/S]
   lept.which low.seiz.thresh., incr.ser.conc. with felbamate, mefloquine   skin les., pregn. & lactat., sev.psychos., MAOI, concom.linezolid.  Pramipexole dihydrochlor.monohydr.
   incr.valproic acid metabol.& has convuls.eff., chloroquine poss.low.   Side effects: Bld dyscras., angioed., psychot. epis.incl.delus/hallu-  Indications: Monother./combinat.ther.with levodopa in idiopath.
   seiz.thresh., valproate free ser.lev.incr.by high. prot. bound agents   cinat.& paranoid ideat., bradykinet. episod., confus., anx., fall.anx.,   Parkinson’s dis.
   e.g. aspir., anticoag.eff.of vit.K depend.fact. anticoags.incr., cimetid.&   agitat., dizzin., somnol., dream abnormalit., insomn., incr.l ibido, im-  (S4) TABS, 43/5.4.1/0134, 0133, 0135
   erythromycin poss.incr.ser.lev., valproate bld.lev. decr.by carbapenem   pulse control sympts., atax., extrapyramid. disord., gait abnormalit.,   719542-001: 0,125 mg, 100, R245,65
   antibiot., ser.conc.decr.by anti-epilept.with enzyme induc.eff.  nervousn., decr.ment. acuity, memory impair., disorientat., euphor.,   719543-001: 0,25 mg, 100, R300,01
   ZARONTIN, MC Pharma [P/S]    blepharosp., trismus, incr.trem., numbn, musc. twitch., latent Horner’s   719545-001: 1,0 mg, 100, R1 204,18
                                                              Dosage: Swall.with water. Admin.dly.dos.in 3 equal. div.dos. Init.
   Ethosuximide.                syndr.activat., periph. neuropathy, NMS, paraesthes., blurr.vis., di-  0,125 mg 3x/day incr.to 0,25 mg 3x dly in 2  wk & 0,5 mg 3x/day
                                                                                nd
   Indications: Absence (petit mal) epilep.  lat. pupils, oculogryric.cris., diplop., card.irregular., palpitat., MI, hy-  in 3  wk. accord.to respons. Maint: Indiv.dos.should be in range of
                                                                rd
   (S3) SYRUP, B559. 250 mg/5 ml.  potens., orthostat.effs., phlebit., oed., dyspn., URTI, pharyng.pain,   0,375 mg to max.of 4,5 mg/day. Dly. dos. may be incr.if need.by
   779105-001: 200 ml, R329,90.  cough, dark saliva, duod.ulc., anorex., vomit., diarrh., constip., dys-  0,75 mg at wkly. interv. to max.4,5 mg dly. Treatm.discont: Taper dos.
   Dosage: Safety in childr.und.3 yrs.not est. May be admin.in com-  peps., dry mouth, taste alterat., GI pain & bleed., dysphag., sialorrh.,   off at rate of 0,75 mg dly.unt.dly.dos of 0,75 mg reach. Theraft. reduc.
   binat.with other anticonvuls. when other epilep.forms coexist with   flatul., bruxism, tong. burn.sensat., heartburn, hiccups, abdom.pain &   dos. by 0,375 mg dly. Concom. levodopa ther: Reduce levodopa dos.
   absence eplepsy              distress, rash, icr.sweat., alopec., dark sweat.& urine, malign.mela-  grad.dur.both dos. escalat. & maint.treatm.unt.optim.respons. achiev.
   Init.dos: 3-6 yrs: 5 ml (250 mg)/day. 6 yrs.& old: 10 ml (500 mg)/day   noma, flush., prurit., bulb.les., back/should & leg apin, musc.cramps,   Contraindications: Childr.bel.18 yrs., safety in pregn. & lactat.not est.
   Maint: Indiv.accord.to pt. respon. Dos.to be incr.in small increm.of   UTI, urin. freq./-retent./-incontin., priapism, chest pain, asthen., fat.,   Side effects: Somnol., GI disturbs., CNS effs., dizzin., asthen., ac-
   250 mg/ day every 4-7 days until control achiev. Dos. exceed. 1,5 g   bizar.breath.patterns, faintn., hoarsen., malaise, hot flush., sense of   cid.inj., extrapyramid.syndr., headache, confus., hallucinat., oed., ma-
   dly.for an adult in div.dos.should only be admin.under strict.supervis.   stimulat., weight gain/-loss  laise, fev., syncope, post.hypotens., vasodilat., hypertens., tachycard.,
   Optim.childr.dos: 20 mg/kg/day.  Warnings and special precautions: Not recomm. for drug-  chest pain, dry mouth, anorex., dysphag., abdom./back/neck pain, leg
   Contraindications: Succinimide hypersens.  induc.extrapyramid.reacts., discont. levodopa monother.12 hrs.bef.  cramps, twitch., tremor, hyperton., decr.libido, depress., anx., atax.,
   Side effects: Leucopen., agranulocytos., aplast. anaem., eosino-  init.ther.& substit.at dos.provid.approx.20% of prev.levodopa dos.,   hypokines., paralys., paraesthes., gait abnormal., vertigo, skin reacts.,
   phil., pancytopen with/-out bone marr. suppress., allerg.react., ano-  poss dyskines.in pts.prev.receiv.levodopa alone theref.dos.reduct.  sweat., impot., UTI, urin.freq./incont., rhinit., dyspn., sinusit., flu syndr.,
   rex., aggressiven., euphor., irritabil., depress.with overt suicid.intent.,   poss., sev.CV/pulm.dis., bronch.asthma, ren./hepat./endocr.dis.,   pharyngit., incr.cough, allerg.react., infect., voice alter., conjunctivit.,
   sleep disturbs., incr.libido, incr. paranoid psychos., night terr., dizzin.,   hist.of pept.ulc.dis., convuls., MI hist., monit.card.funct. esp.dur.init.  incr.saliva, arthrit., arthralg., myalg., apathy, pneum., tooth disord.,
   drowsin., headache, hyperactiv., atax., inability to conc., myopia,   dos.adjustm., period.eval.of hepat./ haematopoiet./CV & ren.funct.,   periph.oed., fall.asleep without warn.
   hiccups, abdom. pain, cramps, epigastric pain, vague gastric up-  early diagnos.of poss.NMS., chron.wide-angle glauc., monit.for for   Special precautions: Alert dr.in case pregn. occurs/ pregn.plann.
   set, N&V, diarrh., gum hypertrophy, tong.swell., prurit., erythemat.   poss.melanoma/depress with suic.tenden./antisoc. behav./impuls.  dur.ther., may be excret.in breast milk, fall.asleep.dur.dly.liv.activ.,
   rashes, urticar., Stev.-Johns.syndr., haematur., proteinur., vag.bleed.,   contr.disords, psych.disturbs./ psychot. states, eval.ability to drive/  re-assess. pts. reg.for drowsin.& sleepin., pt.to be advis.of drowsin.
   fatig., lethargy, weight loss.  operat.mach., excret.in breast milk., safety & effic.in childr.und. 18   potent.bef.init.treatm., concom.sedat. meds./ exist.sleep disords.&
   Warning and special precautions: Poss.incr. in grand mal seiz.  yrs.not est.& not recomm.  concom.meds.incr. pramipexole plasma lev., poss.ther.discont.if
   when used alone in mix.type epilep., incr./decr.dos.grad., addit./  Drug interactions: Poss.postur.hypotens.with antihypertens., sev.  signif. dayt.sleepin.esp.dur.activ.requir.act. particip./ potent.danger.
   elimin.of other meds., period.bld.counts., liv.& ren.dis., eval. pts. for   orthostat.hypotens.with selegiline, hypertens/dyskines.with TCA’s, Fe   activ., dos.reduct.may not reduc. fall.asleep episod., concom.other
   depress./anx.& suicidality, pts.prev. exhibit. psychologic.abnormalit.  salts may reduc.bioavail., metoclopramide incr.bioavail., phenytoin/  anti-parkinson. meds., ren.funct.impairm., withdr.grad., reg. oph-
   may display psych./ psychologic. aberrat.more freq., DRESS syndr.   papaverine/haloperidol/isoniaz decr. effectiven., dopamine D 2 recept.  thalmolog.monit.in case of vis.abnorm., warn. pts.of poss.orthostat.
   rarely report.post market., poss.imp.ment. & physic. abilit.reqd.for   agon.reduc.effs., high protein diet impair.absorpt.  hypotens./hallucinat./ confus., caut.pts.against rising rapid.aft.sitt./
   perform.potent.hazard. tasks., period. ser. lev.of other antiepilept.,   MADOPAR, Roche [P/S]  lying down for long per.esp.at treatm.init./dos.escalat., elderly, poss.
   cross. placenta with birth defects report., excret. in human breast milk.  Levodopa 200 mg, benserazide HCl 50 mg.  cause/exacerbat.of pre-exist. dyskines., admin.with food poss.reduc.
   Interactions: Poss.interacts.with other concurr. antiepilept.  Indications: Parkinsonism of idiopathic & symptomat.variet.excl.  naus., patholog. chang.in retina of albino rats, poss. neurolept. ma-
                                drug-induc.Parkinsonism.      lign.syndr.with abrupt withdr., sev. CV dis., monit.BP esp.init., concom.
                                (S4) TABS, P/5.4.1/150        meds.incr. Oxpola plasm lev.
   1.7    Anti-Parkinson agents  739928-007: 100, R833,62     Drug interactions: Incr.levodopa C max & decr.T max, incr. AUC & half life
                                Dosage: Pref.to admin.apart from food. Indiv.
                                                              with cimetidine, poss.interact. with amantidine, clear.decr.by drugs
                                Init: ½ tab 3xdly. Incr.by ½ tab.wkly.until indiv. therapeut.dos.reach.   secret.by cation. transport syst., eff.poss.diminish.by dopamine an-
   1.7.1  Dopaminergics         Effect.dos.gen.2-4 tabs dly.in div.dos. Max.5 tabs.dly. Contin.ther.for   tagon., poss.addit.effs.of CNS depress. & alcoh.
                                at least 6 mnths.bef.presum.ineffect.
                                Maint: 1 tab 3xdly.adapt.to indiv.requirem. For pts.who experience   PEXASP, Aspen Pharmacare: Pharma)
   CARBILEV, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  large fluctuat.in drug’s eff more freq/smaller sngl.dos/switch to contr.  Pharmacare [P/S]
   Carbidopa 25(25) mg, levodopa 100(250) mg.  rel.formulat/seek alt medicat.  Pramipexole dihydrochlor. monohydr.
   Indications: Parkinson.dis.& syndr.  Change over from L-dopa: See manufact.prod. lit.  Indications: Monother./combinat.ther.with levodopa in idiopath.
   (S4) TABS. 30/5.4.1/0271, 0269.  (S4) HBS CAPS. 31/5.4.1/0194.  Parkinson’s dis.
   824321-006: 25/100 mg, 100, R414,00  Levodopa 100 mg, benserazide HCl 25 mg.  (S4) TABS, 42/5.4.1/1023, 1022, 1024
   824348-001: 25/250 mg, 100, R563,00  Indications:. All types of fluctuat.(ie peak dos.dyskines.& end of   723741-001: 0,125 mg, 100, R237,36
   Dosage: Titrate dos. Pts.not already treat.with levodopa: Init 1 tab of   dos.deteriorat.)  723740-001: 0,25 mg, 100, R292,14
   Carbilev 25/100 3x/day. Incr.dos.by 1 tab.dly/on alt.days as necess.to   828483-019: 100, R778,25  723742-001: 1 mg, 100, R949,45
   max. 8 tabs.dly. Pts.start.with Carbilev 25/250: Init dos: ½ tab.1-2xdly.   Dosage: Swallow cap.without chew. Pref.to admin.apart from food.  Dosage: Admin.with food reduc.poss.naus. Admin. dly.dos.3x/day in
   An addit. ½ tab.may be added every day/every other day until optim.  When switch.from Madopar tabs.to HBS caps the switch is made   equal.div.dos. Init. 0,375 mg/day incr.every 5-7 days depend.on toler.
   respons. Carbidopa dos. greater than 200 mg dly.gen.not exceed.  from one day to the next begin.with morn.dos. Keep the same dly   Titrat. to max.therap.eff. Recomm.dly.dos.sched: Wk 1: 0,375 mg/
   Maint.dos: 1 Carbilev 25/250 tab.3xdly. This dos. may be incr.by   dos.& same interv. Aft 2-3 days incr.the dos grad.by about 50% due   day. Wk.2: 0,75 mg/day. Wk 3: 1,50 mg/day. If furth dos. incr. necess.
   ½-1 tab.every day or every other day to max. 8 tabs.dly. Reduc.  to low.bioavailability. Onset of act.approx.3 hrs. Carry out indiv.ti-  incr.dly.dos.by 0,75 mg at wkly. interv.to max.of 4,5 mg/day. Dos.high.
   grad.upon discont.           trat.slow.in interv.of at least 2-3 days. In pts.with nocturn.immobil.  than 1,5 mg/ day incr.somnol.incid.
   Contraindications: MAOI, clos.angle glauc., hist. of melanoma/   posit.effs.report aft.grad.incr.last even.dos.up to3 caps.at bedt. Contr   Maint: Indiv.dos.in range of 0,375 mg to max. 4,50 mg /day.
   undiag.skin les., women of child bear.age, pregn. lactat., childr.  over-responsiveness by incr.length of interv.betw administrat.rather   Concom.ther: Levodopa ther.to be reduc.both dur.escalat. & maint.
   und.18 yrs.not est.          than by reduc.sngl.dos. In case of poor respons.to HBS resume prev.  treatm.to avoid excess. dopaminerg. stimulat.
   Side effects: Dyskines., akines., trem., rigidity, syndr.resembl.neu-  treatm.with Madopar tabs.   Side effects: Pneum., UTI, inappropr.antidiuret. horm.secret., in-
   rolept.malign.syndr.with abrupt discontinuat., GI disturbs., GI bleed.  Contraindications: MAOI, decompensat. endocrine, ren./hepat./  somn., psych.disords., libido/ weight chang., pathalog.gambl., binge
   in pts.with pept.ulc.hist., orthostat.hypotens., hypertens., card.ar-  card.disords., glauc., psychos., highly pronoun.psychoneuros., pts.  eat., compuls. shopp., hyperphag., hypersex., restlessn., delirium,
   rhythm., psychiatr.sympts., aggress., paranoid delus., hallucinat., de-  und.25 yrs., pregn., lactat.  man., CNS effs., dizzin., extrapyramid. syndr., dyskines., akathis.,</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page72.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page68.html">68</a>&nbsp;&nbsp;&nbsp;<a href="page69.html">69</a>&nbsp;&nbsp;&nbsp;<a href="page70.html">70</a>&nbsp;&nbsp;&nbsp;<a href="page71.html">71</a>&nbsp;&nbsp;&nbsp;<a href="page72.html">72</a>&nbsp;&nbsp;&nbsp;<a href="page73.html">73</a>&nbsp;&nbsp;&nbsp;<a href="page74.html">74</a>&nbsp;&nbsp;&nbsp;<a href="page75.html">75</a>&nbsp;&nbsp;&nbsp;<a href="page76.html">76</a>&nbsp;&nbsp;&nbsp;<a href="page77.html">77</a>&nbsp;&nbsp;&nbsp;<a href="page78.html">78</a>
             </td>
             <td width="35%"><a href="page74.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page74.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
